1. Home
  2. PGEN vs TATT Comparison

PGEN vs TATT Comparison

Compare PGEN & TATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • TATT
  • Stock Information
  • Founded
  • PGEN 1998
  • TATT 1985
  • Country
  • PGEN United States
  • TATT Israel
  • Employees
  • PGEN N/A
  • TATT N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • TATT Aerospace
  • Sector
  • PGEN Health Care
  • TATT Industrials
  • Exchange
  • PGEN Nasdaq
  • TATT Nasdaq
  • Market Cap
  • PGEN 344.0M
  • TATT 308.2M
  • IPO Year
  • PGEN N/A
  • TATT 1987
  • Fundamental
  • Price
  • PGEN $1.53
  • TATT $26.33
  • Analyst Decision
  • PGEN Strong Buy
  • TATT Strong Buy
  • Analyst Count
  • PGEN 4
  • TATT 1
  • Target Price
  • PGEN $7.33
  • TATT $35.00
  • AVG Volume (30 Days)
  • PGEN 1.4M
  • TATT 162.3K
  • Earning Date
  • PGEN 05-13-2025
  • TATT 05-21-2025
  • Dividend Yield
  • PGEN N/A
  • TATT N/A
  • EPS Growth
  • PGEN N/A
  • TATT 96.08
  • EPS
  • PGEN N/A
  • TATT 1.00
  • Revenue
  • PGEN $3,925,000.00
  • TATT $152,116,000.00
  • Revenue This Year
  • PGEN $189.12
  • TATT $18.62
  • Revenue Next Year
  • PGEN $1,093.07
  • TATT $10.62
  • P/E Ratio
  • PGEN N/A
  • TATT $27.61
  • Revenue Growth
  • PGEN N/A
  • TATT 33.68
  • 52 Week Low
  • PGEN $0.65
  • TATT $11.03
  • 52 Week High
  • PGEN $2.17
  • TATT $33.83
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 52.21
  • TATT 46.63
  • Support Level
  • PGEN $1.33
  • TATT $28.07
  • Resistance Level
  • PGEN $1.49
  • TATT $33.83
  • Average True Range (ATR)
  • PGEN 0.14
  • TATT 2.40
  • MACD
  • PGEN 0.02
  • TATT 0.10
  • Stochastic Oscillator
  • PGEN 95.45
  • TATT 23.96

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About TATT TAT Technologies Ltd.

TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.

Share on Social Networks: